The global Erectile Dysfunction Medicine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Erectile Dysfunction Medicine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Erectile Dysfunction Medicine.

Report Scope

The Erectile Dysfunction Medicine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Erectile Dysfunction Medicine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Erectile Dysfunction Medicine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Erectile Dysfunction Medicine Market Report

Report Metric	Details
Report Name	Erectile Dysfunction Medicine Market
CAGR	5%
Segment by Type	Viagra Cialis Levitra Stendra
Segment by Application	Online Pharmacies Retail Pharmacies Hospital
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Pfizer, Inc., Dong-A ST Co., Ltd., Eli Lilly and Company, Bayer AG, Vivus, Inc., Teva Pharmaceutical Industries Ltd., SK Chemicals, Meda Pharmaceuticals, Inc., Cristalia Produtos Quimicos Farmaceuticos Ltda, Apricus Biosciences, Inc., Futura Medical plc.
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Erectile Dysfunction Medicine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Erectile Dysfunction Medicine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Erectile Dysfunction Medicine Market report?

Ans: The main players in the Erectile Dysfunction Medicine Market are Pfizer, Inc., Dong-A ST Co., Ltd., Eli Lilly and Company, Bayer AG, Vivus, Inc., Teva Pharmaceutical Industries Ltd., SK Chemicals, Meda Pharmaceuticals, Inc., Cristalia Produtos Quimicos Farmaceuticos Ltda, Apricus Biosciences, Inc., Futura Medical plc.

What are the Application segmentation covered in the Erectile Dysfunction Medicine Market report?

Ans: The Applications covered in the Erectile Dysfunction Medicine Market report are Online Pharmacies, Retail Pharmacies, Hospital

What are the Type segmentation covered in the Erectile Dysfunction Medicine Market report?

Ans: The Types covered in the Erectile Dysfunction Medicine Market report are Viagra, Cialis, Levitra, Stendra

1 Erectile Dysfunction Medicine Market Overview

1.1 Product Overview and Scope of Erectile Dysfunction Medicine

1.2 Erectile Dysfunction Medicine Segment by Type

1.2.1 Global Erectile Dysfunction Medicine Market Value Comparison by Type (2024-2030)

1.2.2 Viagra

1.2.3 Cialis

1.2.4 Levitra

1.2.5 Stendra

1.3 Erectile Dysfunction Medicine Segment by Application

1.3.1 Global Erectile Dysfunction Medicine Market Value by Application: (2024-2030)

1.3.2 Online Pharmacies

1.3.3 Retail Pharmacies

1.3.4 Hospital

1.4 Global Erectile Dysfunction Medicine Market Size Estimates and Forecasts

1.4.1 Global Erectile Dysfunction Medicine Revenue 2019-2030

1.4.2 Global Erectile Dysfunction Medicine Sales 2019-2030

1.4.3 Global Erectile Dysfunction Medicine Market Average Price (2019-2030)

1.5 Assumptions and Limitations

2 Erectile Dysfunction Medicine Market Competition by Manufacturers

2.1 Global Erectile Dysfunction Medicine Sales Market Share by Manufacturers (2019-2024)

2.2 Global Erectile Dysfunction Medicine Revenue Market Share by Manufacturers (2019-2024)

2.3 Global Erectile Dysfunction Medicine Average Price by Manufacturers (2019-2024)

2.4 Global Erectile Dysfunction Medicine Industry Ranking 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Erectile Dysfunction Medicine, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Erectile Dysfunction Medicine, Product Type & Application

2.7 Erectile Dysfunction Medicine Market Competitive Situation and Trends

2.7.1 Erectile Dysfunction Medicine Market Concentration Rate

2.7.2 The Global Top 5 and Top 10 Largest Erectile Dysfunction Medicine Players Market Share by Revenue

2.7.3 Global Erectile Dysfunction Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Erectile Dysfunction Medicine Retrospective Market Scenario by Region

3.1 Global Erectile Dysfunction Medicine Market Size by Region: 2019 Versus 2023 Versus 2030

3.2 Global Erectile Dysfunction Medicine Global Erectile Dysfunction Medicine Sales by Region: 2019-2030

3.2.1 Global Erectile Dysfunction Medicine Sales by Region: 2019-2024

3.2.2 Global Erectile Dysfunction Medicine Sales by Region: 2025-2030

3.3 Global Erectile Dysfunction Medicine Global Erectile Dysfunction Medicine Revenue by Region: 2019-2030

3.3.1 Global Erectile Dysfunction Medicine Revenue by Region: 2019-2024

3.3.2 Global Erectile Dysfunction Medicine Revenue by Region: 2025-2030

3.4 North America Erectile Dysfunction Medicine Market Facts & Figures by Country

3.4.1 North America Erectile Dysfunction Medicine Market Size by Country: 2019 VS 2023 VS 2030

3.4.2 North America Erectile Dysfunction Medicine Sales by Country (2019-2030)

3.4.3 North America Erectile Dysfunction Medicine Revenue by Country (2019-2030)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Erectile Dysfunction Medicine Market Facts & Figures by Country

3.5.1 Europe Erectile Dysfunction Medicine Market Size by Country: 2019 VS 2023 VS 2030

3.5.2 Europe Erectile Dysfunction Medicine Sales by Country (2019-2030)

3.5.3 Europe Erectile Dysfunction Medicine Revenue by Country (2019-2030)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Erectile Dysfunction Medicine Market Facts & Figures by Country

3.6.1 Asia Pacific Erectile Dysfunction Medicine Market Size by Country: 2019 VS 2023 VS 2030

3.6.2 Asia Pacific Erectile Dysfunction Medicine Sales by Country (2019-2030)

3.6.3 Asia Pacific Erectile Dysfunction Medicine Revenue by Country (2019-2030)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Erectile Dysfunction Medicine Market Facts & Figures by Country

3.7.1 Latin America Erectile Dysfunction Medicine Market Size by Country: 2019 VS 2023 VS 2030

3.7.2 Latin America Erectile Dysfunction Medicine Sales by Country (2019-2030)

3.7.3 Latin America Erectile Dysfunction Medicine Revenue by Country (2019-2030)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Erectile Dysfunction Medicine Market Facts & Figures by Country

3.8.1 Middle East and Africa Erectile Dysfunction Medicine Market Size by Country: 2019 VS 2023 VS 2030

3.8.2 Middle East and Africa Erectile Dysfunction Medicine Sales by Country (2019-2030)

3.8.3 Middle East and Africa Erectile Dysfunction Medicine Revenue by Country (2019-2030)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 U.A.E

4 Segment by Type

4.1 Global Erectile Dysfunction Medicine Sales by Type (2019-2030)

4.1.1 Global Erectile Dysfunction Medicine Sales by Type (2019-2024)

4.1.2 Global Erectile Dysfunction Medicine Sales by Type (2025-2030)

4.1.3 Global Erectile Dysfunction Medicine Sales Market Share by Type (2019-2030)

4.2 Global Erectile Dysfunction Medicine Revenue by Type (2019-2030)

4.2.1 Global Erectile Dysfunction Medicine Revenue by Type (2019-2024)

4.2.2 Global Erectile Dysfunction Medicine Revenue by Type (2025-2030)

4.2.3 Global Erectile Dysfunction Medicine Revenue Market Share by Type (2019-2030)

4.3 Global Erectile Dysfunction Medicine Price by Type (2019-2030)

5 Segment by Application

5.1 Global Erectile Dysfunction Medicine Sales by Application (2019-2030)

5.1.1 Global Erectile Dysfunction Medicine Sales by Application (2019-2024)

5.1.2 Global Erectile Dysfunction Medicine Sales by Application (2025-2030)

5.1.3 Global Erectile Dysfunction Medicine Sales Market Share by Application (2019-2030)

5.2 Global Erectile Dysfunction Medicine Revenue by Application (2019-2030)

5.2.1 Global Erectile Dysfunction Medicine Revenue by Application (2019-2024)

5.2.2 Global Erectile Dysfunction Medicine Revenue by Application (2025-2030)

5.2.3 Global Erectile Dysfunction Medicine Revenue Market Share by Application (2019-2030)

5.3 Global Erectile Dysfunction Medicine Price by Application (2019-2030)

6 Key Companies Profiled

6.1 Pfizer, Inc.

6.1.1 Pfizer, Inc. Corporation Information

6.1.2 Pfizer, Inc. Description and Business Overview

6.1.3 Pfizer, Inc. Erectile Dysfunction Medicine Sales, Revenue and Gross Margin (2019-2024)

6.1.4 Pfizer, Inc. Erectile Dysfunction Medicine Product Portfolio

6.1.5 Pfizer, Inc. Recent Developments/Updates

6.2 Dong-A ST Co., Ltd.

6.2.1 Dong-A ST Co., Ltd. Corporation Information

6.2.2 Dong-A ST Co., Ltd. Description and Business Overview

6.2.3 Dong-A ST Co., Ltd. Erectile Dysfunction Medicine Sales, Revenue and Gross Margin (2019-2024)

6.2.4 Dong-A ST Co., Ltd. Erectile Dysfunction Medicine Product Portfolio

6.2.5 Dong-A ST Co., Ltd. Recent Developments/Updates

6.3 Eli Lilly and Company

6.3.1 Eli Lilly and Company Corporation Information

6.3.2 Eli Lilly and Company Description and Business Overview

6.3.3 Eli Lilly and Company Erectile Dysfunction Medicine Sales, Revenue and Gross Margin (2019-2024)

6.3.4 Eli Lilly and Company Erectile Dysfunction Medicine Product Portfolio

6.3.5 Eli Lilly and Company Recent Developments/Updates

6.4 Bayer AG

6.4.1 Bayer AG Corporation Information

6.4.2 Bayer AG Description and Business Overview

6.4.3 Bayer AG Erectile Dysfunction Medicine Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Bayer AG Erectile Dysfunction Medicine Product Portfolio

6.4.5 Bayer AG Recent Developments/Updates

6.5 Vivus, Inc.

6.5.1 Vivus, Inc. Corporation Information

6.5.2 Vivus, Inc. Description and Business Overview

6.5.3 Vivus, Inc. Erectile Dysfunction Medicine Sales, Revenue and Gross Margin (2019-2024)

6.5.4 Vivus, Inc. Erectile Dysfunction Medicine Product Portfolio

6.5.5 Vivus, Inc. Recent Developments/Updates

6.6 Teva Pharmaceutical Industries Ltd.

6.6.1 Teva Pharmaceutical Industries Ltd. Corporation Information

6.6.2 Teva Pharmaceutical Industries Ltd. Description and Business Overview

6.6.3 Teva Pharmaceutical Industries Ltd. Erectile Dysfunction Medicine Sales, Revenue and Gross Margin (2019-2024)

6.6.4 Teva Pharmaceutical Industries Ltd. Erectile Dysfunction Medicine Product Portfolio

6.6.5 Teva Pharmaceutical Industries Ltd. Recent Developments/Updates

6.7 SK Chemicals

6.6.1 SK Chemicals Corporation Information

6.6.2 SK Chemicals Description and Business Overview

6.6.3 SK Chemicals Erectile Dysfunction Medicine Sales, Revenue and Gross Margin (2019-2024)

6.4.4 SK Chemicals Erectile Dysfunction Medicine Product Portfolio

6.7.5 SK Chemicals Recent Developments/Updates

6.8 Meda Pharmaceuticals, Inc.

6.8.1 Meda Pharmaceuticals, Inc. Corporation Information

6.8.2 Meda Pharmaceuticals, Inc. Description and Business Overview

6.8.3 Meda Pharmaceuticals, Inc. Erectile Dysfunction Medicine Sales, Revenue and Gross Margin (2019-2024)

6.8.4 Meda Pharmaceuticals, Inc. Erectile Dysfunction Medicine Product Portfolio

6.8.5 Meda Pharmaceuticals, Inc. Recent Developments/Updates

6.9 Cristalia Produtos Quimicos Farmaceuticos Ltda

6.9.1 Cristalia Produtos Quimicos Farmaceuticos Ltda Corporation Information

6.9.2 Cristalia Produtos Quimicos Farmaceuticos Ltda Description and Business Overview

6.9.3 Cristalia Produtos Quimicos Farmaceuticos Ltda Erectile Dysfunction Medicine Sales, Revenue and Gross Margin (2019-2024)

6.9.4 Cristalia Produtos Quimicos Farmaceuticos Ltda Erectile Dysfunction Medicine Product Portfolio

6.9.5 Cristalia Produtos Quimicos Farmaceuticos Ltda Recent Developments/Updates

6.10 Apricus Biosciences, Inc.

6.10.1 Apricus Biosciences, Inc. Corporation Information

6.10.2 Apricus Biosciences, Inc. Description and Business Overview

6.10.3 Apricus Biosciences, Inc. Erectile Dysfunction Medicine Sales, Revenue and Gross Margin (2019-2024)

6.10.4 Apricus Biosciences, Inc. Erectile Dysfunction Medicine Product Portfolio

6.10.5 Apricus Biosciences, Inc. Recent Developments/Updates

6.11 Futura Medical plc.

6.11.1 Futura Medical plc. Corporation Information

6.11.2 Futura Medical plc. Erectile Dysfunction Medicine Description and Business Overview

6.11.3 Futura Medical plc. Erectile Dysfunction Medicine Sales, Revenue and Gross Margin (2019-2024)

6.11.4 Futura Medical plc. Erectile Dysfunction Medicine Product Portfolio

6.11.5 Futura Medical plc. Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Erectile Dysfunction Medicine Industry Chain Analysis

7.2 Erectile Dysfunction Medicine Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Erectile Dysfunction Medicine Production Mode & Process

7.4 Erectile Dysfunction Medicine Sales and Marketing

7.4.1 Erectile Dysfunction Medicine Sales Channels

7.4.2 Erectile Dysfunction Medicine Distributors

7.5 Erectile Dysfunction Medicine Customers

8 Erectile Dysfunction Medicine Market Dynamics

8.1 Erectile Dysfunction Medicine Industry Trends

8.2 Erectile Dysfunction Medicine Market Drivers

8.3 Erectile Dysfunction Medicine Market Challenges

8.4 Erectile Dysfunction Medicine Market Restraints

9 Research Finding and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Pfizer Inc

Dong-A ST Co., Ltd

Eli Lilly and Company

Bayer

VIVUS

Teva Pharmaceutical Industries Ltd

SK Chemicals

Meda Pharmaceuticals Inc.

Cristalia Produtos Quimicos Farmaceuticos Ltda.

Apricus Biosciences Inc

Futura Medical plc.

List of Tables

Table 1. Global Erectile Dysfunction Medicine Market Value Comparison by Type (2024-2030) & (US$ Million)

Table 2. Global Erectile Dysfunction Medicine Market Value Comparison by Application (2024-2030) & (US$ Million)

Table 3. Global Erectile Dysfunction Medicine Market Competitive Situation by Manufacturers in 2023

Table 4. Global Erectile Dysfunction Medicine Sales (K Units) of Key Manufacturers (2019-2024)

Table 5. Global Erectile Dysfunction Medicine Sales Market Share by Manufacturers (2019-2024)

Table 6. Global Erectile Dysfunction Medicine Revenue (US$ Million) by Manufacturers (2019-2024)

Table 7. Global Erectile Dysfunction Medicine Revenue Share by Manufacturers (2019-2024)

Table 8. Global Market Erectile Dysfunction Medicine Average Price (US$/Unit) of Key Manufacturers (2019-2024)

Table 9. Global Key Players of Erectile Dysfunction Medicine, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Erectile Dysfunction Medicine, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Erectile Dysfunction Medicine, Product Type & Application

Table 12. Global Key Manufacturers of Erectile Dysfunction Medicine, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Erectile Dysfunction Medicine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Erectile Dysfunction Medicine as of 2023)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Erectile Dysfunction Medicine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 17. Global Erectile Dysfunction Medicine Sales by Region (2019-2024) & (K Units)

Table 18. Global Erectile Dysfunction Medicine Sales Market Share by Region (2019-2024)

Table 19. Global Erectile Dysfunction Medicine Sales by Region (2025-2030) & (K Units)

Table 20. Global Erectile Dysfunction Medicine Sales Market Share by Region (2025-2030)

Table 21. Global Erectile Dysfunction Medicine Revenue by Region (2019-2024) & (US$ Million)

Table 22. Global Erectile Dysfunction Medicine Revenue Market Share by Region (2019-2024)

Table 23. Global Erectile Dysfunction Medicine Revenue by Region (2025-2030) & (US$ Million)

Table 24. Global Erectile Dysfunction Medicine Revenue Market Share by Region (2025-2030)

Table 25. North America Erectile Dysfunction Medicine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 26. North America Erectile Dysfunction Medicine Sales by Country (2019-2024) & (K Units)

Table 27. North America Erectile Dysfunction Medicine Sales by Country (2025-2030) & (K Units)

Table 28. North America Erectile Dysfunction Medicine Revenue by Country (2019-2024) & (US$ Million)

Table 29. North America Erectile Dysfunction Medicine Revenue by Country (2025-2030) & (US$ Million)

Table 30. Europe Erectile Dysfunction Medicine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 31. Europe Erectile Dysfunction Medicine Sales by Country (2019-2024) & (K Units)

Table 32. Europe Erectile Dysfunction Medicine Sales by Country (2025-2030) & (K Units)

Table 33. Europe Erectile Dysfunction Medicine Revenue by Country (2019-2024) & (US$ Million)

Table 34. Europe Erectile Dysfunction Medicine Revenue by Country (2025-2030) & (US$ Million)

Table 35. Asia Pacific Erectile Dysfunction Medicine Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 36. Asia Pacific Erectile Dysfunction Medicine Sales by Region (2019-2024) & (K Units)

Table 37. Asia Pacific Erectile Dysfunction Medicine Sales by Region (2025-2030) & (K Units)

Table 38. Asia Pacific Erectile Dysfunction Medicine Revenue by Region (2019-2024) & (US$ Million)

Table 39. Asia Pacific Erectile Dysfunction Medicine Revenue by Region (2025-2030) & (US$ Million)

Table 40. Latin America Erectile Dysfunction Medicine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Latin America Erectile Dysfunction Medicine Sales by Country (2019-2024) & (K Units)

Table 42. Latin America Erectile Dysfunction Medicine Sales by Country (2025-2030) & (K Units)

Table 43. Latin America Erectile Dysfunction Medicine Revenue by Country (2019-2024) & (US$ Million)

Table 44. Latin America Erectile Dysfunction Medicine Revenue by Country (2025-2030) & (US$ Million)

Table 45. Middle East & Africa Erectile Dysfunction Medicine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 46. Middle East & Africa Erectile Dysfunction Medicine Sales by Country (2019-2024) & (K Units)

Table 47. Middle East & Africa Erectile Dysfunction Medicine Sales by Country (2025-2030) & (K Units)

Table 48. Middle East & Africa Erectile Dysfunction Medicine Revenue by Country (2019-2024) & (US$ Million)

Table 49. Middle East & Africa Erectile Dysfunction Medicine Revenue by Country (2025-2030) & (US$ Million)

Table 50. Global Erectile Dysfunction Medicine Sales (K Units) by Type (2019-2024)

Table 51. Global Erectile Dysfunction Medicine Sales (K Units) by Type (2025-2030)

Table 52. Global Erectile Dysfunction Medicine Sales Market Share by Type (2019-2024)

Table 53. Global Erectile Dysfunction Medicine Sales Market Share by Type (2025-2030)

Table 54. Global Erectile Dysfunction Medicine Revenue (US$ Million) by Type (2019-2024)

Table 55. Global Erectile Dysfunction Medicine Revenue (US$ Million) by Type (2025-2030)

Table 56. Global Erectile Dysfunction Medicine Revenue Market Share by Type (2019-2024)

Table 57. Global Erectile Dysfunction Medicine Revenue Market Share by Type (2025-2030)

Table 58. Global Erectile Dysfunction Medicine Price (US$/Unit) by Type (2019-2024)

Table 59. Global Erectile Dysfunction Medicine Price (US$/Unit) by Type (2025-2030)

Table 60. Global Erectile Dysfunction Medicine Sales (K Units) by Application (2019-2024)

Table 61. Global Erectile Dysfunction Medicine Sales (K Units) by Application (2025-2030)

Table 62. Global Erectile Dysfunction Medicine Sales Market Share by Application (2019-2024)

Table 63. Global Erectile Dysfunction Medicine Sales Market Share by Application (2025-2030)

Table 64. Global Erectile Dysfunction Medicine Revenue (US$ Million) by Application (2019-2024)

Table 65. Global Erectile Dysfunction Medicine Revenue (US$ Million) by Application (2025-2030)

Table 66. Global Erectile Dysfunction Medicine Revenue Market Share by Application (2019-2024)

Table 67. Global Erectile Dysfunction Medicine Revenue Market Share by Application (2025-2030)

Table 68. Global Erectile Dysfunction Medicine Price (US$/Unit) by Application (2019-2024)

Table 69. Global Erectile Dysfunction Medicine Price (US$/Unit) by Application (2025-2030)

Table 70. Pfizer, Inc. Corporation Information

Table 71. Pfizer, Inc. Description and Business Overview

Table 72. Pfizer, Inc. Erectile Dysfunction Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 73. Pfizer, Inc. Erectile Dysfunction Medicine Product

Table 74. Pfizer, Inc. Recent Developments/Updates

Table 75. Dong-A ST Co., Ltd. Corporation Information

Table 76. Dong-A ST Co., Ltd. Description and Business Overview

Table 77. Dong-A ST Co., Ltd. Erectile Dysfunction Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 78. Dong-A ST Co., Ltd. Erectile Dysfunction Medicine Product

Table 79. Dong-A ST Co., Ltd. Recent Developments/Updates

Table 80. Eli Lilly and Company Corporation Information

Table 81. Eli Lilly and Company Description and Business Overview

Table 82. Eli Lilly and Company Erectile Dysfunction Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 83. Eli Lilly and Company Erectile Dysfunction Medicine Product

Table 84. Eli Lilly and Company Recent Developments/Updates

Table 85. Bayer AG Corporation Information

Table 86. Bayer AG Description and Business Overview

Table 87. Bayer AG Erectile Dysfunction Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 88. Bayer AG Erectile Dysfunction Medicine Product

Table 89. Bayer AG Recent Developments/Updates

Table 90. Vivus, Inc. Corporation Information

Table 91. Vivus, Inc. Description and Business Overview

Table 92. Vivus, Inc. Erectile Dysfunction Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 93. Vivus, Inc. Erectile Dysfunction Medicine Product

Table 94. Vivus, Inc. Recent Developments/Updates

Table 95. Teva Pharmaceutical Industries Ltd. Corporation Information

Table 96. Teva Pharmaceutical Industries Ltd. Description and Business Overview

Table 97. Teva Pharmaceutical Industries Ltd. Erectile Dysfunction Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 98. Teva Pharmaceutical Industries Ltd. Erectile Dysfunction Medicine Product

Table 99. Teva Pharmaceutical Industries Ltd. Recent Developments/Updates

Table 100. SK Chemicals Corporation Information

Table 101. SK Chemicals Description and Business Overview

Table 102. SK Chemicals Erectile Dysfunction Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 103. SK Chemicals Erectile Dysfunction Medicine Product

Table 104. SK Chemicals Recent Developments/Updates

Table 105. Meda Pharmaceuticals, Inc. Corporation Information

Table 106. Meda Pharmaceuticals, Inc. Description and Business Overview

Table 107. Meda Pharmaceuticals, Inc. Erectile Dysfunction Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 108. Meda Pharmaceuticals, Inc. Erectile Dysfunction Medicine Product

Table 109. Meda Pharmaceuticals, Inc. Recent Developments/Updates

Table 110. Cristalia Produtos Quimicos Farmaceuticos Ltda Corporation Information

Table 111. Cristalia Produtos Quimicos Farmaceuticos Ltda Description and Business Overview

Table 112. Cristalia Produtos Quimicos Farmaceuticos Ltda Erectile Dysfunction Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 113. Cristalia Produtos Quimicos Farmaceuticos Ltda Erectile Dysfunction Medicine Product

Table 114. Cristalia Produtos Quimicos Farmaceuticos Ltda Recent Developments/Updates

Table 115. Apricus Biosciences, Inc. Corporation Information

Table 116. Apricus Biosciences, Inc. Description and Business Overview

Table 117. Apricus Biosciences, Inc. Erectile Dysfunction Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 118. Apricus Biosciences, Inc. Erectile Dysfunction Medicine Product

Table 119. Apricus Biosciences, Inc. Recent Developments/Updates

Table 120. Futura Medical plc. Corporation Information

Table 121. Futura Medical plc. Description and Business Overview

Table 122. Futura Medical plc. Erectile Dysfunction Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 123. Futura Medical plc. Erectile Dysfunction Medicine Product

Table 124. Futura Medical plc. Recent Developments/Updates

Table 125. Key Raw Materials Lists

Table 126. Raw Materials Key Suppliers Lists

Table 127. Erectile Dysfunction Medicine Distributors List

Table 128. Erectile Dysfunction Medicine Customers List

Table 129. Erectile Dysfunction Medicine Market Trends

Table 130. Erectile Dysfunction Medicine Market Drivers

Table 131. Erectile Dysfunction Medicine Market Challenges

Table 132. Erectile Dysfunction Medicine Market Restraints

Table 133. Research Programs/Design for This Report

Table 134. Key Data Information from Secondary Sources

Table 135. Key Data Information from Primary Sources

List of Figures

Figure 1. Product Picture of Erectile Dysfunction Medicine

Figure 2. Global Erectile Dysfunction Medicine Market Value Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global Erectile Dysfunction Medicine Market Share by Type in 2023 & 2030

Figure 4. Viagra Product Picture

Figure 5. Cialis Product Picture

Figure 6. Levitra Product Picture

Figure 7. Stendra Product Picture

Figure 8. Global Erectile Dysfunction Medicine Market Value Comparison by Application (2024-2030) & (US$ Million)

Figure 9. Global Erectile Dysfunction Medicine Market Share by Application in 2023 & 2030

Figure 10. Online Pharmacies

Figure 11. Retail Pharmacies

Figure 12. Hospital

Figure 13. Global Erectile Dysfunction Medicine Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 14. Global Erectile Dysfunction Medicine Market Size (2019-2030) & (US$ Million)

Figure 15. Global Erectile Dysfunction Medicine Sales (2019-2030) & (K Units)

Figure 16. Global Erectile Dysfunction Medicine Average Price (US$/Unit) & (2019-2030)

Figure 17. Erectile Dysfunction Medicine Report Years Considered

Figure 18. Erectile Dysfunction Medicine Sales Share by Manufacturers in 2023

Figure 19. Global Erectile Dysfunction Medicine Revenue Share by Manufacturers in 2023

Figure 20. The Global 5 and 10 Largest Erectile Dysfunction Medicine Players: Market Share by Revenue in 2023

Figure 21. Erectile Dysfunction Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023

Figure 22. Global Erectile Dysfunction Medicine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Figure 23. North America Erectile Dysfunction Medicine Sales Market Share by Country (2019-2030)

Figure 24. North America Erectile Dysfunction Medicine Revenue Market Share by Country (2019-2030)

Figure 25. U.S. Erectile Dysfunction Medicine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 26. Canada Erectile Dysfunction Medicine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 27. Europe Erectile Dysfunction Medicine Sales Market Share by Country (2019-2030)

Figure 28. Europe Erectile Dysfunction Medicine Revenue Market Share by Country (2019-2030)

Figure 29. Germany Erectile Dysfunction Medicine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 30. France Erectile Dysfunction Medicine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 31. U.K. Erectile Dysfunction Medicine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 32. Italy Erectile Dysfunction Medicine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 33. Russia Erectile Dysfunction Medicine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 34. Asia Pacific Erectile Dysfunction Medicine Sales Market Share by Region (2019-2030)

Figure 35. Asia Pacific Erectile Dysfunction Medicine Revenue Market Share by Region (2019-2030)

Figure 36. China Erectile Dysfunction Medicine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 37. Japan Erectile Dysfunction Medicine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 38. South Korea Erectile Dysfunction Medicine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 39. India Erectile Dysfunction Medicine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 40. Australia Erectile Dysfunction Medicine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 41. Taiwan Erectile Dysfunction Medicine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 42. Indonesia Erectile Dysfunction Medicine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 43. Thailand Erectile Dysfunction Medicine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 44. Malaysia Erectile Dysfunction Medicine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 45. Philippines Erectile Dysfunction Medicine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 46. Latin America Erectile Dysfunction Medicine Sales Market Share by Country (2019-2030)

Figure 47. Latin America Erectile Dysfunction Medicine Revenue Market Share by Country (2019-2030)

Figure 48. Mexico Erectile Dysfunction Medicine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 49. Brazil Erectile Dysfunction Medicine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 50. Argentina Erectile Dysfunction Medicine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 51. Middle East & Africa Erectile Dysfunction Medicine Sales Market Share by Country (2019-2030)

Figure 52. Middle East & Africa Erectile Dysfunction Medicine Revenue Market Share by Country (2019-2030)

Figure 53. Turkey Erectile Dysfunction Medicine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 54. Saudi Arabia Erectile Dysfunction Medicine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 55. U.A.E Erectile Dysfunction Medicine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 56. Global Sales Market Share of Erectile Dysfunction Medicine by Type (2019-2030)

Figure 57. Global Revenue Market Share of Erectile Dysfunction Medicine by Type (2019-2030)

Figure 58. Global Erectile Dysfunction Medicine Price (US$/Unit) by Type (2019-2030)

Figure 59. Global Sales Market Share of Erectile Dysfunction Medicine by Application (2019-2030)

Figure 60. Global Revenue Market Share of Erectile Dysfunction Medicine by Application (2019-2030)

Figure 61. Global Erectile Dysfunction Medicine Price (US$/Unit) by Application (2019-2030)

Figure 62. Erectile Dysfunction Medicine Value Chain

Figure 63. Erectile Dysfunction Medicine Production Process

Figure 64. Channels of Distribution (Direct Vs Distribution)

Figure 65. Distributors Profiles

Figure 66. Bottom-up and Top-down Approaches for This Report

Figure 67. Data Triangulation

Figure 68. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions